<DOC>
	<DOCNO>NCT01516567</DOCNO>
	<brief_summary>Phase II trial determine efficacy Dose Adjusted-EPOCH-Rituximab regimen child adolescent primary mediastinal large B cell lymphoma term event free survival .</brief_summary>
	<brief_title>Intergroup Trial Children Adolescents With Primary Mediastinal Large B-Cell Lymphoma : DA-EPOCH-Rituximab Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Histologically proven Primary Mediastinal Large BCell Lymphoma ( PMLBL ) . PMLBL without central nervous system ( CNS ) involvement . 6 month le 18 year age time consent . Males female reproductive potential must agree use effective contraceptive method treatment , end treatment : twelve month woman , take account characteristic rituximab Complete initial workup within 8 day prior treatment allow definite staging . Able comply schedule followup management toxicity . Signed informed consent patient and/or parent legal guardian Follicular lymphoma , mucosaassociated lymphoid tissue ( MALT ) nodular marginal zone PMLBL patient CNS involvement Patients congenital immunodeficiency , chromosomal breakage syndrome , prior organ transplantation , previous malignancy type , know positive HIV serology . Evidence pregnancy lactation period . There exclusion criterion base organ function . Past current anticancer treatment except corticosteroid le one week . Tumor cell negative CD20 Prior exposure rituximab . Severe active viral infection , especially hepatitis B . Hepatitis B carrier status history hepatitis B virus ( HBV ) positive serology . Participation another investigational drug clinical trial . Patients , reason , able comply national legislation .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>